z-logo
Premium
A quantitative evaluation of the neurospasmolytic effect of orphenadrine by direct and telemedographed electromyography
Author(s) -
Levine Irving M.,
Jossmann Paul B.,
DeAngelis Vincent
Publication year - 1967
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt196781part186
Subject(s) - medicine , electromyography , anesthesia , physical medicine and rehabilitation
Orphenfldrine was evaluated as a neurospasmolytic agent in 14 patients and as an antitremor agent in 2 patients. Response to single 100 mg. doses was measured 1 and 2 hours after medication, and the effect of maintenance therapy with 100 mg. twice a day was measured weekly for 4 weeks. Orphenadrine appeared to be highly effective in the 1 and 2 hour tests but less effective with sustained treatment. In all instances telemedography showed patients had a higher percentage of favorable responses. Orphenadrine was clearly effective in reducing intention tremor in the 2 patients tested with sustained treatment, but less so in the 1 and 2 hour observations.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom